BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31010905)

  • 1. Health Supervision for Children With Neurofibromatosis Type 1.
    Miller DT; Freedenberg D; Schorry E; Ullrich NJ; Viskochil D; Korf BR; ;
    Pediatrics; 2019 May; 143(5):. PubMed ID: 31010905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health supervision for children with neurofibromatosis.
    Hersh JH;
    Pediatrics; 2008 Mar; 121(3):633-42. PubMed ID: 18310216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial Features of Neurofibromatosis Type 1 in Children and Adolescents.
    Domon-Archambault V; Gagnon L; BenoƮt A; Perreault S
    J Child Neurol; 2018 Mar; 33(3):225-232. PubMed ID: 29318935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Care recommendations for type 1 neurofibromatosis].
    Donadio A; Garavelli L; Lorenzetti ME; Villani AR; Banchini G; Virdis R
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):83-7. PubMed ID: 11424620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developmental manifestation in children with neurofibromatosis type 1].
    Cohen R; Shuper A
    Harefuah; 2010 Jan; 149(1):49-52, 61. PubMed ID: 20422842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatosis type 1 (NF1): diagnosis and management.
    Ferner RE; Gutmann DH
    Handb Clin Neurol; 2013; 115():939-55. PubMed ID: 23931823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.
    DeBella K; Szudek J; Friedman JM
    Pediatrics; 2000 Mar; 105(3 Pt 1):608-14. PubMed ID: 10699117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1 system-based manifestations and treatments: a review.
    Saleh M; Dib A; Beaini S; Saad C; Faraj S; El Joueid Y; Kotob Y; Saoudi L; Emmanuel N
    Neurol Sci; 2023 Jun; 44(6):1931-1947. PubMed ID: 36826455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
    Santoro C; Bernardo P; Coppola A; Pugliese U; Cirillo M; Giugliano T; Piluso G; Cinalli G; Striano S; Bravaccio C; Perrotta S
    Ital J Pediatr; 2018 Mar; 44(1):41. PubMed ID: 29566708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anxiety disorders in type 1 neurofibromatosis: A case report].
    Fekih-Romdhane F; Othman S; Sahnoun C; Helayem S; Abbes Z; Bouden A
    Arch Pediatr; 2015 Sep; 22(9):956-60. PubMed ID: 26228808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in diagnosis and treatment of neurofibromatosis type 1].
    Zheng JW; Sun J; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2007 Dec; 16(6):561-9. PubMed ID: 18278402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type 1.
    Cimino PJ; Gutmann DH
    Handb Clin Neurol; 2018; 148():799-811. PubMed ID: 29478615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetics of type 1 neurofibromatosis].
    Garavelli L; Donadio A; Sigorini M; Grassi L; Banchini G
    Acta Biomed Ateneo Parmense; 2000; 71(3-4):89-95. PubMed ID: 11424621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Diagnosis and Management of Neurofibromatosis Type 1.
    Ly KI; Blakeley JO
    Med Clin North Am; 2019 Nov; 103(6):1035-1054. PubMed ID: 31582003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing neurofibromatosis type I in children.
    Davis RE
    Nurse Pract; 1997 Apr; 22(4):73-6, 79-81. PubMed ID: 9128879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.
    Monroe CL; Dahiya S; Gutmann DH
    Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 1: update on a common genetic condition.
    Siqveland E; Pond D
    Minn Med; 2009 Mar; 92(3):49-52. PubMed ID: 19400389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.